[Ovid] Safety and Tolerability During a 4-Week Continuous Subcutaneous Infusion of ABBV-951, a New Drug Formulation for the Treatment of Parkinson＊s Disease: Final Results of a Phase 1b Study (1384) Closed
|
Reward10points
|
10
How I Do It: Managing Human Parvovirus B19 Infections in Solid Organ Transplant Recipients
10
A 16-week multicomponent exercise training program improves menopause-related symptoms in middle-aged women. The FLAMENCO project randomized control trial
10
Localization and Network Connectivity of Lesions Causing Limb Ataxia in Patients With Stroke
10
How I Do It: Managing Human Parvovirus B19 Infections in Solid Organ Transplant Recipients
10
Assessing the Significance of Electrographically Positive Exercise Stress Tests in Patients Attending Cardiac Rehabilitation
